Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
7.12 AUD
-0.28%
Market Closed
Updated:
May 10, 2024
Mayne Pharma Group Ltd
Gross Profit
|
Mayne Pharma Group Ltd
Gross Profit Peer Comparison
Comparables:
RCE
NEU
BOT
PBP
C
CU6
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Gross Profit
AU$90.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Probiotec Ltd
ASX:PBP
|
Gross Profit
AU$66.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
10%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Gross Profit?
Gross Profit
90.4m
AUD
90.4m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Gross Profit amounts to 90.4m AUD.
What is Mayne Pharma Group Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
-20%
-20%
Over the last year, the Gross Profit growth was 20%. The average annual Gross Profit growth rates for Mayne Pharma Group Ltd have been -25% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
